Summary of responses to the key questions in stage 1
| Question | Number of responses (%) | ||
| Yes | No | Missing | |
| Do you routinely offer phase III cardiac rehabilitation to people with heart failure? (n=224) | 90 (40.1) | 134 (59.9) | NA |
| Which of these best describes the heart failure pathway into cardiac rehabilitation in your area? | |||
| Usually only if they have been referred for acute myocardial infarction or revascularisation (n=90) | 39 (43.3) | 12 (13.3) | 39 (43.4) |
| We offer cardiac rehabilitation to all people with heart failure regardless of the cause (n=90) | 56 (62.2) | 17 (18.9) | 17 (18.9) |
| We don't usually take people with diastolic heart failure (n=90) | 11 (12.2) | 22 (24.4) | 57 (63.3) |
| Do you provide a separate programme for heart failure patients? (n=90) | 35 (38.9) | 52 (57.8) | 3 (3.3) |
| If yes, are spouses/partners invited to participate in cardiac rehabilitation? (n=90) | 37 (41.1) | 29 (32.2) | 24 (26.7) |
| Do you provide a home-based cardiac rehabilitation programme for heart failure? (n=90) | 27 (30.0) | 56 (62.2) | 7 (7.8) |
| Do you provide a hospital- /centre-based programme for patients with heart failure? (n=90) | 72 (80.0) | 15 (16.7) | 3 (3.3) |
| Do you offer heart failure patients a choice of home- or centre-based cardiac rehabilitation? (n=90) | 30 (33.3) | 56 (62.2) | 4 (4.4) |
| Do you offer cardiac rehabilitation to New York Heart Association class IV patients? (n=90) | 16 (17.8) | 56 (62.2) | 18 (20.0) |
| Do any of the following factors influence you in offering/not offering cardiac rehabilitation to people with heart failure? | |||
| Not enough resources (n=90) | 29 (32.2) | 50 (55.6) | 11 (12.2) |
| HF patients are not included in our contract with the commissioners (n=90) | 16 (17.8) | 54 (60.0) | 20 (22.2) |
| We are not confident that we have the right skill mix/knowledge to manage these patients (n=90) | 8 (8.9) | 67 (74.4) | 15 (16.7) |
| Lack of evidence/guidance on safety (n=90) | 6 (6.7) | 71 (78.9) | 13 (14.4) |
| Lack of evidence on clinical benefit (n=90) | 2 (2.6) | 74 (82.2) | 14 (15.6) |
NA, not applicable.